Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection

NCT01560468 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Financial Reasons

Conditions

Hepatitis C Infection

Interventions

DRUG: ITX 5061

Sponsor

Schiano, Thomas D., MD

Collaborators

[object Object]